3D Therapy Information

3D Therapy | AI + VR for Lasting Behavior Change In partnership with Mass General Brigham, 3D Therapy is developing Thrive™, an AI + VR Behavior Change Platform to treat Substance Use Disorder. Already granted FDA Breakthrough Device Designation, Thrive™ is designed to make behavior change effective, engaging, and lasting. Thrive™ combines Mindfulness-Based Cognitive Therapy (MBCT) with immersive, gamified experiences to reshape neural pathways and drive deep transformation. Unlike traditional treatments that focus only on surface behaviors, Thrive™ targets the psychological roots of addiction, helping rewire the brain for sustainable change. Inspired by the science of hypnosis, Thrive™ seamlessly integrates therapeutic suggestions, making long-term growth feel natural and achievable. By providing immediate craving and mood relief while addressing underlying psychological drivers, Thrive™ is revolutionizing addiction care. 🚀 With FDA Breakthrough Designation secured and early results promising, we’re building the future of treatment. THE PROBLEM: SUD is a growing crisis, affecting 46M+ people in the U.S. annually, yet only 10% receive treatment due to stigma, cost, and lack of access. The economic burden exceeds $600B per year, while traditional treatment models fail to scale or provide personalized, evidence-based care. THE OPPORTUNITY: Digital therapeutics and integrated care solutions offer scalable, cost-effective interventions that improve outcomes and reduce costs. The SUD treatment market is projected to surpass $42B by 2030, driven by policy reforms and tech advancements. THE SOLUTION: Thrive improves retention, mood and cravings for OUD patients in detox, with clinical trial participants achieving a 74% decrease in depression, 60% decrease in cravings, 70% decrease in anxiety and 41% increase in retention.